Pure Global AI
Manufacturer profile

Teknimed SAS

TaiwanFrance2 products registeredNov 26, 2013 – Jun 10, 2022
VerifiedTFDA · Taiwan Food and Drug Administration registry
2
Total products
2
Product types
1
Active products
Jun 2022
Latest registration
Company details
Address
11-12 rue d’Apollo - 31240 L’ Union – France
Regulatory footprint
Search Teknimed SAS across other regulatory registries
ThailandEuropean UnionColombiaSouth KoreaCanadaEcuador
Recent registrations
Latest 5 products registered by this manufacturer
“TEKNIMED” NANOGEL Synthetic Bone Substitute
Class 2
Jun 10, 2022
“TEKNIMED” COHESION BONE CEMENT
Class 2
Nov 26, 2013
Most popular products
Products with most registrations
“TEKNIMED” NANOGEL Synthetic Bone Substitute
1 registrations
“TEKNIMED” COHESION BONE CEMENT
1 registrations
Authorized representatives
Taiwan authorized representatives for this manufacturer
GREAT UNITED STRONG ENTERPRISE CO., LTD.
1 products
STRYKER FAR EAST INC. TAIWAN BRANCH (USA)
1 products
Recent registered products
Most recent products (showing top 20)
“TEKNIMED” NANOGEL Synthetic Bone Substitute
Registered: Jun 10, 2022 • Expires: Jun 10, 2027
Risk Class
Class 2
Type
MD
AR
GREAT UNITED STRONG ENTERPRISE CO., LTD.
“TEKNIMED” COHESION BONE CEMENT
Registered: Nov 26, 2013 • Expires: Nov 26, 2023
Cancelled
Risk Class
Class 2
Type
MD
AR
STRYKER FAR EAST INC. TAIWAN BRANCH (USA)
About this profile

Explore comprehensive manufacturer profile for Teknimed SAS based in France through Pure Global AI's free Taiwan medical device database. This manufacturer has 2 products registered in Taiwan across 2 unique product categories. Their regulatory history spans from Nov 26, 2013 to Jun 10, 2022.

This page provides detailed insights including 2 recent product registrations, 2 most popular products with “TEKNIMED” NANOGEL Synthetic Bone Substitute having 1 registrations, and 2 authorized representatives including GREAT UNITED STRONG ENTERPRISE CO., LTD.. Pure Global AI offers free access to Taiwan's medical device database, enabling global MedTech companies to analyze market dynamics and identify opportunities.